Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats.

PURPOSE Elevation of diacylglycerol (DAG) and protein kinase C (PKC) levels in diabetic vascular tissue is associated with abnormalities of retinal and renal hemodynamics. The object of this study was to determine whether direct elevation of retinal DAG levels, in the absence of diabetes or hyperglycemia, can mimic the hemodynamic abnormalities normally observed in diabetic rats. Retinal DAG levels were elevated using an inhibitor of DAG kinase that converts DAG to phosphatidic acid. The effectiveness of a specific PKC-beta isoform inhibitor introduced directly into the retinas of diabetic rats in reversing diabetes-related abnormal retinal hemodynamics was also investigated. METHODS For retinal blood flow studies, diacylglycerol kinase (DGK) inhibitor R59949, at various concentrations, was injected into the vitreous of nondiabetic Sprague-Dawley rats (n = 33), and a PKC-beta isoform-selective inhibitor LY333531 was injected into the vitreous of rats with streptozotocin (STZ)-induced diabetes of 2 weeks' duration (n = 21). Retinal hemodynamic changes were quantitated using video-based fluorescein angiography. Total DAG levels were assayed from five nondiabetic rat retinas after DGK inhibition and retinal PKC activities were assayed from six diabetic rat retinas after PKC-beta inhibition. RESULTS DGK inhibitor R59949 injected into the vitreous dose dependently increased the mean circulation time (MCT) and decreased retinal blood flow (EC50 = 10(-8) M). After 30 minutes, 10(-5) M R59949 induced a 1.7-fold increase in total retinal DAG levels, compared with the levels in vehicle-injected eyes, an increase in MCT from 0.87 +/- 0.05 seconds to 1.44 +/- 0.12 seconds (P < 0.01) and a decrease in retinal blood flow from 105.3 +/- 6.5 pixel2/second to 64.1 +/- 5 pixel2/second (P < 0.01). The effect of R59949 was sustained for 60 minutes after injection. These retinal hemodynamic parameters after DGK inhibition were comparable to those measured at baseline in rats with STZ-induced diabetes of 2 weeks' duration (MCT = 1.38 +/- 0.20 seconds; retinal blood flow = 68 +/- 11.2 pixel2/second). Intravitreal injection of the PKC-beta inhibitor (LY333531) at 10(-5) M in diabetic rats decreased by a factor of 1.6 the diabetes-related increased PKC activation, decreased the prolonged MCT (0.98 +/- 0.13 seconds; P < 0.01) and increased retinal blood flow (93.4 +/- 14.2 pixel2/second; P < 0.01). The measured retinal circulatory parameters after PKC inhibition in the retina were comparable to those measured at baseline in the nondiabetic rats. CONCLUSIONS These results provide direct evidence that DAG elevation and subsequent PKC-beta isoform activation are the primary biochemical sequelae responsible for the development of the abnormal retinal hemodynamics observed in diabetic rats.

[1]  S. Bursell,et al.  Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor , 1996, Science.

[2]  F. De Clerck,et al.  The role of endogenously formed diacylglycerol in the propagation and termination of platelet activation. A biochemical and functional analysis using the novel diacylglycerol kinase inhibitor, R 59 949. , 1989, The Journal of biological chemistry.

[3]  Toyoshi Inoguchi,et al.  Induction of Resistance to Endothelin-1's Biochemical Actions by Elevated Glucose Levels in Retinal Pericytes , 1992 .

[4]  A. Hughes,et al.  A supplement to the cat schematic eye , 1976, Vision Research.

[5]  C. Riva,et al.  Fluorescein dye-dilution technique and retinal circulation. , 1978, The American journal of physiology.

[6]  G. King,et al.  Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. Kern,et al.  Progression of Incipient Diabetic Retinopathy During Good Glycemic Control , 1987, Diabetes.

[8]  E. Kohner,et al.  Production of Endothelin 1 by Cultured Bovine Retinal Endothelial Cells and Presence of Endothelin Receptors on Associated Pericytes , 1989, Diabetes.

[9]  C T Dollery,et al.  Estimation of retinal blood flow by measurement of the mean circulation time. , 1971, Cardiovascular research.

[10]  J. Pirart.  Diabetes Mellitus and Its Degenerative Complications: A Prospective Study of 4,400 Patients Observed Between 1947 and 1973 , 1978, Diabetes Care.

[11]  G T Feke,et al.  Retinal circulatory abnormalities in type 1 diabetes. , 1994, Investigative ophthalmology & visual science.

[12]  B. Brenner,et al.  Pathogenesis of diabetic microangiopathy. The hemodynamic view. , 1986, The American journal of medicine.

[13]  S. Bursell,et al.  Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. , 1996, Investigative ophthalmology & visual science.

[14]  H. Bohlen,et al.  Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. , 1993, The American journal of physiology.

[15]  G. King,et al.  Reversal of abnormal retinal hemodynamics in diabetic rats by acarbose, an alpha-glucosidase inhibitor. , 1995, Current eye research.

[16]  R. Schrier,et al.  Characterization of Glucose-Induced In Situ Protein Kinase C Activity in Cultured Vascular Smooth Muscle Cells , 1992, Diabetes.

[17]  S. Bursell,et al.  Hemodynamic changes as early markers of diabetic retinopathy , 1996 .

[18]  S. Bursell,et al.  Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. , 1994, Annual review of medicine.

[19]  G. King,et al.  Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps. , 1994, Investigative ophthalmology & visual science.

[20]  G. King,et al.  Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. , 1994, The American journal of physiology.

[21]  G. Pieper,et al.  Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. , 1992, The American journal of physiology.

[22]  C. Davidson,et al.  Increase in Diacylglycerol Mass in Isolated Glomeruli by Glucose From De Novo Synthesis of Glycerolipids , 1990, Diabetes.

[23]  F. DeRubertis,et al.  Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. , 1989, The Journal of clinical investigation.

[24]  S. Bursell,et al.  Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. , 1993, The American journal of physiology.

[25]  K. Yamada,et al.  Diacylglycerol kinase: a key modulator of signal transduction? , 1990, Trends in biochemical sciences.

[26]  J. Flier,et al.  Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. , 1987, The New England journal of medicine.

[27]  S. Bursell,et al.  Endothelin-1 action via endothelin receptors is a primary mechanism modulating retinal circulatory response to hyperoxia. , 1996, Investigative ophthalmology & visual science.

[28]  G. King,et al.  Characterization of the Mechanism for the Chronic Activation of Diacylglycerol-Protein Kinase C Pathway in Diabetes and Hypergalactosemia , 1994, Diabetes.

[29]  H. Rasmussen,et al.  TPA-induced contraction of isolated rabbit vascular smooth muscle. , 1984, Biochemical and biophysical research communications.

[30]  T. Kern,et al.  Kidney Morphology in Experimental Hyperglycemia , 1987, Diabetes.

[31]  S. Bursell,et al.  Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. , 1996, Investigative ophthalmology & visual science.